Evidence map›Paper›PMID 24901334›Full record

ArticlePLoS neglected tropical diseases2014

A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings.

Andrew Taylor Bright, Micah J Manary, Ryan Tewhey, Eliana M Arango, Tina Wang, Nicholas J Schork, Stephanie K Yanow, Elizabeth A Winzeler

Abstract readCase Reports
In one paragraph

Article in PLoS neglected tropical diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. UnderstandingiScience · 2026
    Article
  5. Article
  6. Article
  7. UnderstandingmedRxiv : the preprint server for health sciences · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Population genomics ofbioRxiv : the preprint server for biology · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Liver-stage fate determination inFrontiers in microbiology · 2022
    Article
  18. Novel highly-multiplexed AmpliSeq targeted assay forFrontiers in cellular and infection microbiology · 2022
    Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andrew Taylor BrightBiomedical Sciences Program, School of Medicine, University of California, San Diego, La Jolla, California, United States of America; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Micah J ManaryBiomedical Sciences Program, School of Medicine, University of California, San Diego, La Jolla, California, United States of America; Department of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Ryan TewheyScripps Genomic Medicine, The Scripps Translational Science Institute, La Jolla, California, United States of America; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Eliana M ArangoGrupo Salud y Comunidad, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia.
Tina WangBiomedical Sciences Program, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Nicholas J SchorkScripps Genomic Medicine, The Scripps Translational Science Institute, La Jolla, California, United States of America; Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, California, United States of America.
Stephanie K YanowSchool of Public Health, University of Alberta, Edmonton, Alberta, Canada; Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.
Elizabeth A WinzelerDepartment of Pediatrics, School of Medicine, University of California, San Diego, La Jolla, California, United States of America.

Funding

SCRIPPS TRANSLATIONAL SCIENCE INSTITUTE (UL1)UL1RR025774 · NCRR · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2008 to 2011
$16.3M
Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Discovery of chemically validated malaria liver stage targetsR01AI090141 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WINZELER, ELIZABETH A · 2011 to 2019
$3.4M
Functional genomic tools for in vivo study of P. vivaxR21AI085374 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI SCHORK, NICHOLAS JOSEPH · 2010 to 2011
$519k
NCRR NIH HHS UL1 RR025774NIAID NIH HHS 1R01AI03058-01A1NIAID NIH HHS 5R01AI090141-03NIAID NIH HHS R01 AI090141NIAID NIH HHS R21 AI085374NIAID NIH HHS R21-AI085374-01A1NIGMS NIH HHS T32 GM008666
6 · The paper itself

Abstract

Plasmodium vivax infects a hundred million people annually and endangers 40% of the world's population. Unlike Plasmodium falciparum, P. vivax parasites can persist as a dormant stage in the liver, known as the hypnozoite, and these dormant forms can cause malaria relapses months or years after the initial mosquito bite. Here we analyze whole genome sequencing data from parasites in the blood of a patient who experienced consecutive P. vivax relapses over 33 months in a non-endemic country. By analyzing patterns of identity, read coverage, and the presence or absence of minor alleles in the initial polyclonal and subsequent monoclonal infections, we show that the parasites in the three infections are likely meiotic siblings. We infer that these siblings are descended from a single tetrad-like form that developed in the infecting mosquito midgut shortly after fertilization. In this natural cross we find the recombination rate for P. vivax to be 10 kb per centimorgan and we further observe areas of disequilibrium surrounding major drug resistance genes. Our data provide new strategies for studying multiclonal infections, which are common in all types of infectious diseases, and for distinguishing P. vivax relapses from reinfections in malaria endemic regions. This work provides a theoretical foundation for studies that aim to determine if new or existing drugs can provide a radical cure of P. vivax malaria.

Indexed as

Genetic VariationAdultGenome, ProtozoanGenotypeHumansMalaria, VivaxMalePlasmodium vivaxRecombination, GeneticRecurrenceSequence Analysis, DNA

Identifiers

PMID24901334
PMCPMC4046966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.